Cognition Therapeutics (CGTX) Institutional Ownership $0.86 +0.06 (+7.34%) As of 11:49 AM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for Cognition Therapeutics (NASDAQ:CGTX)CurrentInstitutional OwnershipPercentage43.35%Number ofInstitutional Buyers(last 12 months)11TotalInstitutional Inflows(last 12 months)$5.54MNumber ofInstitutional Sellers(last 12 months)4TotalInstitutional Outflows(last 12 months)$2.82M Get CGTX Insider Trade Alerts Want to know when executives and insiders are buying or selling Cognition Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data CGTX Institutional Buying and Selling by Quarter Cognition Therapeutics Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails5/21/2025Acadian Asset Management LLC1,007,586$422K0.0%+814.1%1.625% 5/16/2025Northeast Financial Consultants Inc63,351$27K0.0%+158.6%0.102% 5/14/2025Voss Capital LP450,000$189K0.0%-10.0%0.726% 5/9/2025CM Management LLC400,000$168K0.2%+100.0%0.645% 2/17/2025Two Sigma Investments LP53,691$38K0.0%+372.2%0.129% 2/14/2025Voss Capital LP500,000$351K0.0%N/A1.203% 2/12/2025Geode Capital Management LLC352,348$247K0.0%+8.9%0.848% 2/11/2025Virtu Financial LLC80,180$56K0.0%+40.1%0.193% 2/10/2025BIOS Capital Management LP6,000,000$4.21M4.5%N/A14.441% 2/7/2025CM Management LLC200,000$140K0.1%-20.0%0.481% Get the Latest News and Ratings for CGTX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Cognition Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 2/3/2025Sigma Planning Corp614,490$431K0.0%+211.6%1.479% 1/17/2025SG Americas Securities LLC37,108$26K0.0%N/A0.089% 11/20/2024Virtu Financial LLC57,231$27K0.0%N/A0.138% 11/4/2024Sigma Planning Corp197,190$92K0.0%+14.6%0.491% 8/12/2024Mercer Global Advisors Inc. ADV95,951$159K0.0%+33.4%0.240% 8/9/2024Renaissance Technologies LLC89,718$149K0.0%-42.4%0.224% 8/7/2024AIGH Capital Management LLC300,766$499K0.2%-84.1%0.751% 8/2/2024CM Management LLC200,000$332K0.3%+14.3%0.499% 7/16/2024 Bangor Savings Bank34,019$56K0.0%+41.6%0.085% 5/16/2024Levin Capital Strategies L.P.30,000$55K0.0%N/A0.075% 5/16/2024AWM Investment Company Inc.650,000$1.18M0.2%N/A1.623% 5/14/2024Carlson Capital L P213,995$389K0.0%-10.1%0.534% 5/14/2024CM Management LLC175,000$318K0.3%N/A0.437% 5/10/2024Tocqueville Asset Management L.P.26,000$47K0.0%N/A0.065% 5/8/2024Hohimer Wealth Management LLC225,000$410K0.1%N/A0.562% 3/5/2024Twin Focus Capital Partners LLC93,372$173K0.0%N/A0.291% 2/8/2024Texas Capital Bank Wealth Management Services Inc55,395$102K0.0%N/A0.172% 2/1/2024Sigma Planning Corp28,550$53K0.0%N/A0.089% 10/23/2023Steward Financial Group LLC40,874$58K0.0%N/A0.135% 7/28/2023Voss Capital LLC60,222$110K0.0%-62.4%0.206% 5/12/2023Voss Capital LLC159,973$317K0.0%-4.2%0.546% 5/12/2023FCA Corp TX51,471$102K0.0%N/A0.176% 2/16/2023AIGH Capital Management LLC2,037,853$4.28M1.4%+155.3%7.030% 2/13/2023Northeast Financial Consultants Inc24,500$51K0.0%N/A0.085% 2/13/2023Voss Capital LLC166,903$350K0.1%-23.8%0.576% 2/13/2023Financial Partners Capital Management LLC14,228$30K0.0%N/A0.049% 2/7/2023Commonwealth Equity Services LLC189,307$397K0.0%-13.6%0.653% 2/6/2023 Neumann Capital Management LLC33,382$70K0.0%N/A0.115% 1/31/2023Kestra Advisory Services LLC50,618$106K0.0%+237.5%0.175% 1/20/2023 Diligent Investors LLC20,000$42K0.0%-34.5%0.069% New Federal Land Rush About to Start? (Ad)A $100 Trillion Wealth Shift Is Already Underway Lithium. Oil. Gold. Trillions in U.S. resources are being quietly opened to the public, and former hedge fund firm manager Whitney Tilson believes this is the best chance in years to turn a small stake into huge gains. He's naming one $10 stock leading this "US: IPO" boom.Click here to see the full story.12/13/2022 Perigon Wealth Management LLC36,900$70K0.0%-70.0%0.127% 11/15/2022Carlson Capital L P100,000$190K0.0%N/A0.440% 11/14/2022Worth Venture Partners LLC200,188$380K0.2%-12.3%0.881% 11/10/2022Rock Creek Group LP50,000$95K0.0%-37.3%0.220% 11/2/2022Voss Capital LLC219,100$416K0.1%-29.2%0.965% 11/1/2022P.A.W. Capital Corp100,000$190K0.3%-25.9%0.440% 10/12/2022 Wealth Alliance Advisory Group LLC18,500$35K0.0%N/A0.081% 8/13/2022Voss Capital LLC309,472$653K0.2%+1,070.5%1.363% 8/13/2022Prosight Management LP120,198$254K0.2%-49.9%0.532% 8/11/2022 Perigon Wealth Management LLC122,846$259K0.0%N/A0.544% 8/8/2022Rock Creek Group LP79,751$170K0.0%+201.6%0.353% 8/1/2022Castle Wealth Management LLC43,380$92K0.1%N/A0.192% 7/19/2022Commonwealth Equity Services LLC214,961$453K0.0%+1,447.6%0.951% 7/13/2022P.A.W. Capital Corp135,000$285K0.4%+12.5%0.597% 5/17/2022Prosight Management LP240,080$660K0.4%-20.5%1.062% 5/4/2022Commonwealth Equity Services LLC13,890$38K0.0%N/A0.061% 4/26/2022 Diligent Investors LLC30,520$84K0.0%N/A0.135% 4/26/2022Kestra Advisory Services LLC238,666$656K0.0%+150.9%1.057% 4/21/2022P.A.W. Capital Corp120,000$330K0.3%+20.0%0.531% 4/14/2022 Bangor Savings Bank18,496$51K0.0%N/A0.082% 2/10/2022B. Riley Financial Inc.30,904$195K0.0%N/A0.140% 2/10/2022American Financial Group Inc.205,000$1.30M0.4%N/A0.930% 2/10/2022AIGH Capital Management LLC25,496$161K0.0%N/A0.116% 2/10/2022P.A.W. Capital Corp100,000$632K0.6%N/A0.454% (Data available from 1/1/2016 forward) CGTX Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of CGTX shares? During the previous two years, 23 institutional investors and hedge funds held shares of Cognition Therapeutics. The most heavily invested institutionals were BIOS Capital Management LP ($4.21M), AWM Investment Company Inc. ($1.18M), AIGH Capital Management LLC ($499K), Sigma Planning Corp ($431K), Acadian Asset Management LLC ($422K), Hohimer Wealth Management LLC ($410K), and Carlson Capital L P ($389K).Learn more on Cognition Therapeutics' institutional investors. What percentage of Cognition Therapeutics' stock is owned by institutional investors? 43.35% of Cognition Therapeutics' stock is owned by institutional investors. Learn more on CGTX's institutional investor holdings. Which institutional investors have been buying Cognition Therapeutics' stock? Of the 19 institutional investors that purchased Cognition Therapeutics' stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: BIOS Capital Management LP ($6M), Acadian Asset Management LLC ($897.35K), AWM Investment Company Inc. ($650K), Voss Capital LP ($500K), Sigma Planning Corp ($470.90K), CM Management LLC ($400K), and Hohimer Wealth Management LLC ($225K). How much institutional buying is happening at Cognition Therapeutics? Institutional investors have bought a total of 8,315,918 shares in the last 24 months. This purchase volume represents approximately $5.54M in transactions. Which of Cognition Therapeutics' major shareholders have been selling company stock? The following institutional investors have sold Cognition Therapeutics stock in the last 24 months: AIGH Capital Management LLC ($1.60M), Renaissance Technologies LLC ($65.98K), Voss Capital LP ($50K), and CM Management LLC ($50K). How much institutional selling is happening at Cognition Therapeutics? Institutional investors have sold a total of 1,762,489 shares in the last 24 months. This volume of shares sold represents approximately $2.82M in transactions. Related Companies Enanta Pharmaceuticals Institutional Ownership Spero Therapeutics Institutional Ownership Lexeo Therapeutics Institutional Ownership Theratechnologies Institutional Ownership Greenwich LifeSciences Institutional Ownership Rapt Therapeutics Institutional Ownership Inhibikase Therapeutics Institutional Ownership Molecular Partners Institutional Ownership Lyell Immunopharma Institutional Ownership Compugen Institutional Ownership This page (NASDAQ:CGTX) was last updated on 7/24/2025 by MarketBeat.com Staff From Our PartnersYour Bank Account Is No Longer SafeWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | SponsoredA new rule goes live in July — and the banks are quietly cashing inA little-known regulation quietly goes into effect this July. And it's already being exploited by Wall Stre...American Alternative | SponsoredGenesis 14:13-17 [HIDDEN MEANING?]A mysterious Bible verse from Genesis may hold the key to unlocking what one expert calls an “American birthri...Paradigm Press | SponsoredBuffett to put 90% of his money in this one stock?CPA and CFA says you have WAY too many stocks - just buy these 3 After years working at the biggest accoun...Altimetry | SponsoredCritical AI announcement set to ignite AI 2.0 I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredBREAKING: The House just passed 3 pro-crypto bills!Experts Believe Altcoin Season is Here! With this new legislation in effect, crypto experts across the coun...Crypto 101 Media | SponsoredTrump’s Endgame? (R.I.P. China)Tucked inside a Silicon Valley factory, a bold new tech is quietly emerging—one that could ignite a $12 trilli...Brownstone Research | SponsoredTreasury Secretary Bessent Is Betting Big on GoldWhen the U.S. Treasury Secretary’s largest personal investment is gold — that’s a signal. Now a veteran gol...Golden Portfolio | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cognition Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Cognition Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
